DexCom Inc (DXCM)
124.33
-13.68
(-9.91%)
USD |
NASDAQ |
Apr 26, 16:00
124.93
+0.60
(+0.48%)
After-Hours: 20:00
DexCom Cash from Financing (TTM): -318.60M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -318.60M |
September 30, 2023 | 312.30M |
June 30, 2023 | 397.20M |
March 31, 2023 | -546.60M |
December 31, 2022 | -552.50M |
September 30, 2022 | -552.30M |
June 30, 2022 | 11.00M |
March 31, 2022 | 14.90M |
December 31, 2021 | 10.40M |
September 30, 2021 | 6.30M |
June 30, 2021 | 0.00 |
March 31, 2021 | 906.40M |
December 31, 2020 | 912.10M |
September 30, 2020 | 916.90M |
June 30, 2020 | 918.40M |
March 31, 2020 | 12.30M |
December 31, 2019 | 10.70M |
September 30, 2019 | 712.40M |
June 30, 2019 | 711.80M |
March 31, 2019 | 711.10M |
December 31, 2018 | 710.40M |
September 30, 2018 | 8.90M |
June 30, 2018 | 7.80M |
March 31, 2018 | 323.00M |
December 31, 2017 | 399.10M |
Date | Value |
---|---|
September 30, 2017 | 399.50M |
June 30, 2017 | 400.30M |
March 31, 2017 | 85.20M |
December 31, 2016 | 8.10M |
September 30, 2016 | 9.80M |
June 30, 2016 | 10.10M |
March 31, 2016 | 15.10M |
December 31, 2015 | 16.80M |
September 30, 2015 | 19.50M |
June 30, 2015 | 20.20M |
March 31, 2015 | 17.50M |
December 31, 2014 | 21.80M |
September 30, 2014 | 21.80M |
June 30, 2014 | 17.60M |
March 31, 2014 | 18.30M |
December 31, 2013 | 11.80M |
September 30, 2013 | 14.20M |
June 30, 2013 | 13.60M |
March 31, 2013 | 11.80M |
December 31, 2012 | 10.20M |
September 30, 2012 | 2.963M |
June 30, 2012 | 2.621M |
March 31, 2012 | 73.84M |
December 31, 2011 | 74.20M |
September 30, 2011 | 107.35M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-552.50M
Minimum
Dec 2022
918.40M
Maximum
Jun 2020
204.37M
Average
12.30M
Median
Mar 2020
Cash from Financing (TTM) Benchmarks
Abbott Laboratories | -7.091B |
Edwards Lifesciences Corp | -711.00M |
Intuitive Surgical Inc | 46.90M |
Cardinal Health Inc | -2.545B |
Insulet Corp | -13.60M |